Mostrar el registro sencillo del ítem

Biopsias percutáneas en lesiones mamarias e importancia de la ecografía como adjunto a la mamografía

dc.contributor.advisorRey Serrano, Juan Joséspa
dc.contributor.authorRojas Rueda, Sandra Patriciaspa
dc.contributor.authorAraújo Reyes, Ana Teresaspa
dc.contributor.authorJaramillo Botero, Nataliaspa
dc.contributor.authorMantilla Suárez, Juan Carlosspa
dc.date.accessioned2021-02-05T13:48:35Z
dc.date.available2021-02-05T13:48:35Z
dc.date.issued2008
dc.identifier.urihttp://hdl.handle.net/20.500.12749/12134
dc.description.abstractEl cáncer de mama es el tumor invasivo más frecuente en mujeres, con más de un millón de casos y cerca de 600.000 muertes al año en todo el mundo (1), con tasas de incidencia más altas en países industrializados, como Estados Unidos, Australia y países de Europa Occidental, que pueden estar relacionadas con mudanzas en los patrones reproductivos así como un mayor uso de la mamografía (2, 3, 4 y 5). La tasa de incidencia no es igual para todos los grupos raciales y étnicos reflejando los diversos grados de desarrollo socioeconómico y características culturales (6). Las tasas promedio anuales de incidencia ajustadas para la edad desde 1996 hasta el 2000 fueron 140,8 casos/100000 entre mujeres blancas, 121,7 entre afroamericanas, 97,2 entre Asiático-americanas/isleñas del pacífico, 89,8 en hispánicas y 58 en indios americanos/nativos de Alaska (6). En América latina según la unión internacional para el control de cáncer, Uruguay, Argentina y Chile tienen la tasa más alta de incidencia y mortalidad por cáncer de mama, mientras que en Perú y México el cáncer cervicouterino sigue ocupando el primer lugar. A nivel mundial se observa una tendencia al aumento del cáncer de mama mientras que el cervicouterino disminuye, sin embargo en Colombia la incidencia de cáncer con una tasa ajustada para la edad fue del 36.8 por cien mil para el cuello uterino y del 30 por cien mil para la mama.spa
dc.description.tableofcontents1. PLANTEAMIENTO DEL PROBLEMA 12 2. JUSTIFICACION 14 3. MARCO TEORICO 15 3.1 TAMIZAJE PARA DETECCIÓN TEMPRANA DE CÁNCER DE MAMA 15 3.2 MÉTODOS DIAGNÓSTICOS EN CÁNCER DE MAMA 17 3.2.1 Mamografía. 17 3.2.2 Ecografía mamaria 22 3.2.3 Birads Combinado Final 37 3.3 METODOS DE OBTENCIÓN DE MUESTRAS PARA ESTUDIO HISTOPATOLÓGICO 38 3.3.1 Biopsia por aspiración con aguja fina 39 3.3.2 Biopsia con aguja gruesa guiada por ecografía 39 3.3.3 Biopsia con aguja gruesa guiada por estereotaxia 40 3.3.4 Radiografía de los cilindros de microbiopsia 41 3.3.5 Biopsia escisional previa marcación con arpón 41 3.3.6 Radiografía de pieza quirúrgica posterior a marcaje con aguja y correlación histopatológica 42 3.3.7 Revisión de la mamografía e histologia de las muestras con aguja gruesa 42 3.4 AUDITORIA BIRADS 43 3.4.1 Sensibilidad y especificidad. 47 3.4.2 Mamografías falsas negativas 47 3.4.3 Valor predictivo positivo 48 3.4.4 Valor predictivo negativo 49 3.4.5 Revisión de los resultados 49 3.4.6 Valor predictivo positivo de la biopsia de mama 50 3.4.7 Causas de mamografía falsas negativas 50 3.5 CLASIFICACIÓN HISTOLÓGICA DE PATOLOGÍA MAMARIA: 51 3.5.1 Lesiones benignas de la mama. 51 3.5.2 Lesiones malignas 54 3.6 FACTORES DE RIESGO 60 3.6.1 Factores de riesgo establecidos 60 3.6.2 Factores de riesgo no establecidos o en investigación 63 4. OBJETIVOS 67 4.1 OBJETIVO GENERAL 67 4.2 OBJETIVOS ESPECÍFICOS 67 5. METODOLOGIA 68 5.1 TIPO DE ESTUDIO 68 5.2 POBLACION 68 5.3 VARIABLES 68 5.4 RECOLECCION DE DATOS 69 5.5 CRITERIOS DE INCLUSION 69 5.6 CRITERIOS DE EXCLUSION 70 5.7 TECNICA DE RECOLECCION 70 5.8 PLAN DE ANALISIS 72 6. RESULTADOS 73 6.1 ANALISIS UNIVARIADO 73 6.2 ANALISIS BIVARIADO 80 7. DISCUSION 106 8. CONCLUSIONES 110 REFERENCIAS BIBLIOGRAFICAS 111spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleBiopsias percutáneas en lesiones mamarias e importancia de la ecografía como adjunto a la mamografíaspa
dc.title.translatedPercutaneous biopsies in breast lesions and the importance of ultrasound as an adjunct to mammographyspa
dc.degree.nameEspecialistas en Radiología e Imágenes Diagnósticasspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programEspecialización en Radiología e Imágenes Diagnósticasspa
dc.description.degreelevelEspecializaciónspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsMedical scienceseng
dc.subject.keywordsHealth scienceseng
dc.subject.keywordsRadiologyeng
dc.subject.keywordsDiagnostic imagingeng
dc.subject.keywordsPercutaneous biopsieseng
dc.subject.keywordsBreast lesionseng
dc.subject.keywordsUltrasoundeng
dc.subject.keywordsMammographyeng
dc.subject.keywordsBreast cancereng
dc.subject.keywordsBreast pathologyeng
dc.subject.keywordsBreast neoplasmseng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.relation.references1. ARC, WHO. Breast cancer, in Stewart B, Kleihues P (Eds). World Cancer Report. Lyon: IARC Press, 2003; 188–19.spa
dc.relation.references2. Armstrong B. Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer. 1976; 17(2):204-211.spa
dc.relation.references3. Flaws, J. A., Bush, T. L., Newschaffer, C. J., Chu, K. C., Tarone, R. E., Brawley, O. W. (2000). Racial Differences in Breast Cancer Mortality. Arch Fam Med 9: 412-413.spa
dc.relation.references4. Ries L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.spa
dc.relation.references5. Miller B, Feuer E, Hankey B. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993; 43: 27–41Cancer 1994; 74: 222–227.spa
dc.relation.references6. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda (MD): nacional Cancer Institute, 2003.spa
dc.relation.references7. Incidencia estimada y mortalidad en Colombia, 1995 – 1999. INSTITUTO NACIONAL DE CANCEROLOGÍA, INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, MINISTERIO DE LA PROTECCIÓN SOCIAL. 2005.spa
dc.relation.references8. Situación de Salud en Santander. Indicadores Básicos. Observatorio de Salud Pública de Santander. 2005.spa
dc.relation.references9. Base de datos del Registro poblacional de cáncer de Bucaramanga y el área Metropolitana.spa
dc.relation.references10. Hall FM, Storella JM, Silverstone DZ, Wyshak G. Nonpalpable breast lesions: recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988; 167:353–358.spa
dc.relation.references11. Orel SG, Kay N, Reynolds C, Sullivan DC. BI-RADS categorization as a predictor of malignancy. Radiology 1999; 211:845–850.spa
dc.relation.references12. Clark R. Principles of cancer screening. Radiol Clin N Am 42 (2004) 735-746spa
dc.relation.references14. Jatoi I. Breast cancer screening. Am J Surg, 1999; 177(6):518-24.spa
dc.relation.references15. Farria DM, Monses B. Screening mammography practice Essentials. Radiol Clin N Am 42 (2004) 831-843.spa
dc.relation.references16. American College of Radiology. Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003.spa
dc.relation.references17. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.spa
dc.relation.references18. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2.spa
dc.relation.references19. NCI statement on mammography screening. Office of Communications/Mass Media Branch. Bethesda, MD: National Institutes of Health; February 21, 2002.spa
dc.relation.references20. Gisvold JJ, Martin JK. Prebiopsy localization of nonpalpable breast lesions. AJR Am J Roentgenol 1984; 143:477.spa
dc.relation.references21. Kopans D. Pathologic, mammographic, abd sonographic correlation. In: Kopans DB(Ed). Breast imaging. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998:511-615.spa
dc.relation.references22. Mendelson EB. The Breast. In Rumack CM. Wilson SR, Charboneau JW (Eds) Diagnostic Ultrasound. 2nd ed. St Louis, MO: CV Mosby CO; 1998:751-790.spa
dc.relation.references23. Moskowitz M. Screening is not diagnosis. Radiology 1979;133:265-8.spa
dc.relation.references24. Tabar L, Faberberg G, Day NE, Holmberg. What is the optimum inteval betwen mammographic screening examinations? an analysis based on the latest results of the Swedish two-country breast cancer screening trial. Br J Cancer 1987;55:547-51.spa
dc.relation.references25. Tabar L, Fagerberg G, Chen H-H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17.spa
dc.relation.references26. Nielson M, Jensen J, Andersen JA. An autopsy study of radial scar in the female breast. Histopathology 1985; 9:287-295.spa
dc.relation.references27. Orel SG, Evers K, Yeh IT, Troupin RH. Radial scar with microcalcifications: radiologi-pathologic correlation. Radiology 1992; 183:470-482.spa
dc.relation.references28. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow up. Br J Cancer. 1994; 70:542-48.spa
dc.relation.references29. Gordon PB. Radiol Clin N Am 40 (2002) 431-41.spa
dc.relation.references30. World Cancer Report IARC. Stewart BW, Kleihues P, editors. 188-219. 2003.spa
dc.relation.references31. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The Breast Imaging Reporting and Data System: positive predictive value of mammographic features and final assessment categories. AJR 1998; 171:35–40.spa
dc.relation.references32. Bérubé M, Curpen B, Ugolini P, Lalonde L, Ouimet-Oliva D. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy. Can Assoc Radiol J 1998; 49:223–228.spa
dc.relation.references33. Baker JA, Kornguth PJ, Lo JY, Floyd CE. Breast cancer: prediction with artificial neural network based on BI-RADS standardized lexicon. Radiology 1995;196:817–822.spa
dc.relation.references34. Holland R, Hendriks JUL, Mravunac M. Mammographically occult breast cancer: a pathologic and radiologic study. Cancer 1983; 52: 1810-1819.spa
dc.relation.references35. Moskowitz M. The predictive value of certain mammographic signs in screening for breast cancer. Cancer 1983; 51:1007-1001.spa
dc.relation.references36. D’Orsi CJ, Kopans DB. Mammography in breast cancer screening BMJ 1995; 311:1189-1193spa
dc.relation.references37. Romero J, Aguirre D. BI-RADS en el informe ecográfico. Rev Col Radiol 2003; 14(1):1325-1332.spa
dc.relation.references38. American college of Radiology. Standard for the performance of the breast US examination. Reston VA ACR 2002.spa
dc.relation.references39. Gordon PB. Ultrasound for breast cancer screening and staging Radiol Clin N Am 2002; 40:431-41.spa
dc.relation.references40. Baker JA, Kornguth PJ, Soo MS, Walsk R y Mengoni P. Sonography of solid breast lesions: observer variability of lesion description and assessment. Am J Roentgenol 1999; 172:1621-1625.spa
dc.relation.references41. Bosh AM, Kessels AGH et al. Interexamination variation of whole breast ultrasound. Br J Radiol 2003; 328-331.spa
dc.relation.references42. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123–134.spa
dc.relation.references43. Ikeda DM. Ecografia mamaria. En Ikeda DM (ed): los requisitos. Radiología de la mama. Elsevier Mosby, Madrid. 2005:131-60.spa
dc.relation.references44. BI-RADS: ultrasound, 1st Ed. In: Breast imaging reporting and data system: BI-RADS atlas, 4th ed. Reston, VA: American College of Radiology, 2003spa
dc.relation.references45. Mendelson EB, Berg WA, Merritt CRB. Toward a standardized breast ultrasound lexicon, BI-RADS: ultrasound. Semin Roentgenol 2001; 36:217–225.spa
dc.relation.references46. Jackson VP. Management of solid breast nodules: hat is the role of sonography? Radiology1995; 196:14–15.spa
dc.relation.references47. Hall FM. Sonography of the breast: controversies and opinions. AJR 1997; 169:1635–1636.spa
dc.relation.references48. Milton SW, Leopold GR, Olson LK, Wilson SA. Real time breast sonography: application in 300 consecutive patients. Am J roentgenoly 1984; 147:479-86.spa
dc.relation.references49. Ciatto S, Cariaggi P, Bulgaresi P. the value of routine cytologic examination of breast cyst fluids. Acta Cytol 1987; 31:301-4.spa
dc.relation.references50. Berg WA. Breast Ultrasonography: Cystic lesions and probable benign findings. In Women’s Imaging: categorical course syllabus. Leesburg VA. American Roentgen Ray Society 2004; 95-101.spa
dc.relation.references51. Venta LA. Management of complex breast cyst. Am J Roentgenol 1999; 173:1331-1336.spa
dc.relation.references52. Kolb TM, Lychi J, Newhouse JH. Occult cancer in women with dense breast: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998; 207:191-9.spa
dc.relation.references53. Palmer JR, Rosemberg L, Rao RS et al. Induced and spontaneous abortion in relation to risk of breast cancer (united status) Cancer Causes control 1997; 8:841-9.spa
dc.relation.references54. Berg WA. Cystic lesions of the breast: sonographic pathologic correlation. Radiology 2003; 227:183-91.spa
dc.relation.references55. Velásquez MV. Manejo de las lesiones quisticas complejas de seno (conferencia). Curso de imágenes de la mujer. Fundación Santa Fe de Bogota, 2003.spa
dc.relation.references56. Berg WA. Can clusters of microcyst appropriately be followed? (abstr). Radiology 2002; 224:1375-1379.spa
dc.relation.references57. Mercado CL, Harmele-Bena D, Sinbger C et al. Papillary lesions of the breast: evaluation with stereotactic direccional vacuum-assisted biopsy. Radiology 2001; 221:650-655.spa
dc.relation.references58. Weinstein SP, Conant EF, Orel SG, Zuckerman JA, Czerniecki B, Lawton TJ. Retrospective review of palpable breast lesions after negative mammography and sonography. J Women’s Imaging 2000; 2:15–18.spa
dc.relation.references59. Kopans DB, Moore RH, Slanetz PJ, Yeh ED, Hall DA, McCarthy KA. The specificity of combined mammographic and ultrasonographic evaluation of palpable lumps and palpable thickening. (abstr) Radiology 1999; 213(P):371).spa
dc.relation.references60. Dennis MA, Parker SH, Klaus AJ, Stavros AT, Kaske TI, Clark SB. Breast biopsy avoidance: the value of normal mammograms and normal sonograms in the setting of a palpable lump. Radiology 2001; 219:186–191.spa
dc.relation.references61. Jackson VP. Management of solid breast nodules: hat is the role of sonography? Radiology1995; 196:14–15.spa
dc.relation.references62. Hall FM. Sonography of the breast: controversies and opinions. AJR 1997; 169:1635–1636.spa
dc.relation.references63. Rahbaret al. Rahbar G, Sie AC, Hansen GC, et al. Benign versus malignant solid breast masses: US differentiation. Radiology 1999; 213:889–894.spa
dc.relation.references64. Soo MS, Rosen E, Baker JA, Vo TT, Boyd BA Negative Predictive Value of Sonography with Mammography in Patients with Palpable Breast Lesions AJR:177, November 2001: 1167-1170.spa
dc.relation.references65. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsies with a biopsy gun. Radiology 1990; 176:741-747.spa
dc.relation.references66. Fornage BD. Cuided needle biopsy of nonpalpable breast lesions: practical issues (Abstr). In: Breast diseases: a Year Book quarterly. St Louis, MO: Mosby-Year Book, 1991; 10-11. Utah: University of Utah Press; 66-68.spa
dc.relation.references67. Parker SH, Jobe WE, Dennis MA, et al. Us guided automated large-core breast biopsy. Radiology 1993; 187:507-511.spa
dc.relation.references68. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994; 193:359-364.spa
dc.relation.references69. Kopans DB: Breast Imaging. Philadelphia: Lippincott-Raven Publishers, 1997: 21, 644.spa
dc.relation.references70. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994; 193:359-364.spa
dc.relation.references71. Youngson BJ, Cranor M, Rosen PP: Epithelial displacement in surgical breast biopsies following needling procedures. Am J Surg Pathol 1994; 18: 896–903.spa
dc.relation.references72. Harter LP, Curtis JS, Ponto G, Craig PH. Malignant seeding of the needle track during stereotaxic core needle breast biopsy. Radiology 1992; 185:713-714.spa
dc.relation.references73. Schackmuth EM, Harlow CL, Norton LW. Milk fistula: a complication after core breast biopsy. AJR 1993; 161:961-962.spa
dc.relation.references74. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsies with a biopsy gun. Radiology 1990; 176:741-747.spa
dc.relation.references75. Parker SH, Lovin JO, Jobe WE, et al. Nonpalpable breast lesions: stereotactic automated large core breast biopsies. Radiology 1991; 180:403-407.spa
dc.relation.references76. Mendez A, Cabanillas F, Echenique M., Malekshamran K, Perez & E. Ramos. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB) Annals of Oncology 14: 450–454, 2003.spa
dc.relation.references77. Sickles E. Periodic mammographic follow up of probably benign lesions: Results of 3184 consecutive cases. Radiology 1991; 79: 463–468.spa
dc.relation.references78. Varas X, Leborgne F, Leborgne J. Nonpalpable, probably benign lesions: Role of follow up mammography. Radiology 1992; 184: 409–414.spa
dc.relation.references79. Verkooijen HM, Peeters PH, Pijnappel RM, et al. Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg 2000; 87:344–7.spa
dc.relation.references80. Hall FM, Frank HA. Preoperative localization of nonpalpable breast lesion. AJR Am J Roentgenol 1979; 132.101-105.spa
dc.relation.references81. Gisvold JJ, Goeliner JR, Grant CS, et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol 1994; 162:815-820.spa
dc.relation.references82. Fletcher SW, Black W, Harris R, et al. Report of the international Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993; 85:1644-1656.spa
dc.relation.references83. Yankaskas BC, Cleveland RJ, Schell MJ, Kozar R. Association of recall rates with sensitivity and positive predictive values of screening mammography. AJR 2001; 177:543–549.spa
dc.relation.references84. Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D’Orsi CJ, Ransohoff DF. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst 2003; 95:1384–1393.spa
dc.relation.references85. Baker LH: Breast cancer detection demonstration project: Five-year summary report. CA Cancer J Clin 1982; 32(4):194-225.spa
dc.relation.references86. Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the Breast Cancer Detection Demonstration Project. C Cancer J Clin 1987; 37:258–290.spa
dc.relation.references87. Britton PD, McCann J, o´Driscoll D, et al. Interval cancer peer review in East Anglia: implications for monitoring doctors as web as NHS breast screening programme. Clin Rad.2000; 56:44-49.spa
dc.relation.references88. Burrel HC, Sibbering DM, Wilson AR, et al. Screening interval cancers: Mammographic features and prognostic factors. Radiology. 1996; 199:811-817.spa
dc.relation.references89. Vitak B. Invasive interval cancers in the Ostergotland mammographic screening programme: Radiological analysis. Eur Radiol. 1998; 8:639-646.spa
dc.relation.references90. Daly CA, Apthorp L, Field S. second round cancers: how many were visible on the first round of the UK national breast screening programme three years earlier? Clin Rad.1998; 53:25-28.spa
dc.relation.references91. Blanks RG, Moss SM, Wallis MG. Monitoring and evaluating the UK National Health Service: Breast Screening Programme: evaluating the variation in radiological performance between individual programmers using PPV-referral diagrams. J Med Screen 2001; 8:24–28.spa
dc.relation.references92. Quality Determinants of Mammography Guideline Panel. Quality determinants of mammography. Rockville, MD: United States Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1994:78–86.spa
dc.relation.references93. Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol 1992; 158:521-526.spa
dc.relation.references94. Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the Breast Cancer Detection Demonstration Project. C Cancer J Clin 1987; 37:258–290.spa
dc.relation.references95. Weinstein SP, Conant EF, Orel SG, Zuckerman JA, Czerniecki B, Lawton TJ. Retrospective review of palpable breast lesions after negative mammography and sonography. J Women’s Imaging 2000; 2:15–18.spa
dc.relation.references96. Kopans DB, Moore RH, Slanetz PJ, Yeh ED, Hall DA, McCarthy KA. The specificity of combined mammographic and ultrasonographic evaluation of palpable lumps and palpable thickening. (abstr) Radiology 1999; 213(P):371.spa
dc.relation.references97. Georgian-Smith D, Shells WE. Freehand interventional sonography in the breast: basic principles and clinical applications. Radiographic 1996; 16:149-161.spa
dc.relation.references98. Tabar L, Fagerberg G, Day N, et al. Breast cancer treatment and natural history: new insights from results of screening. Lancet 1992; 339:412-414.spa
dc.relation.references99. Rosen PP, Groshen S, Saigo PE, et al. A long-term follow-up study of survival in stage I (T1 N0 M0) and stage II (T1 N1 M0) breast carcinoma. J Clin Oncol 1989; 7:355-366.spa
dc.relation.references100. Meyer JE, Kopans DB, Stomper PC, lindfors KK. Occult breast abnormalities: Percutaneous preoperative needle localization. Radiology 1984; 150:335.spa
dc.relation.references101. Gisvold JJ, Martin JK. Prebiopsy localization of nonpalpable breast lesions. AJR Am J Roentgenol 1984; 143:477.spa
dc.relation.references102. Rosenberg AL, Schwartz GF, Feig SA, Patchefsky AS. Clinically occult breast lesions: localization ands significance. Radiology 1987; 162:167spa
dc.relation.references103. Basset LW, Liu TH, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs. impalpable mammographically detected lesions. AJR Am J Roentgenol 1991; 157:21-24.spa
dc.relation.references104. Smart CR. Highlights of the evidence of benefit for women aged 40-49 years from the 14 year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994; 74:296-300.spa
dc.relation.references105. Shaw de Paredes E. Meshed Breast Cancer: Avoiding this pitfall.Applied Radiology 2000; 29:15-21.spa
dc.relation.references106. Bird RE, Wallace TE, Yankaskas BC. Analysis of cancers misssed at screeing mammography. Radiology 1992; 184:613-617.spa
dc.relation.references107. Goergen SK, Evans J, Colen GPB, MacMillan JH: Characteristics of breast carcinomas missed by screening radiologists. Radiology 204:131-135, 1997.spa
dc.relation.references108. Huynh PT, Jarolimek AM, Daye S: The False-negative mammogram. Radiographics 18:1137-1154, 1998.spa
dc.relation.references109. Sloane JP. Biopsy Pathology of the Breast. New York: Wiley, 1985.spa
dc.relation.references110. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312:146.spa
dc.relation.references111. Meyer JE, Frenna TH, Polger M, et al. Enlarging occult fibroadenomas. Radiology 1992; 183:639-645.spa
dc.relation.references112. Kopans D. Pathologic, mammographic, abd sonographic correlation. In: Kopans DB(Ed). Breast imaging. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998:511-615.spa
dc.relation.references113. Mendelson EB. The Breast. In Rumack CM. Wilson SR, Charboneau JW (Eds) Diagnostic Ultrasound. 2nd ed. St Louis, MO: CV Mosby CO; 1998:751-790spa
dc.relation.references114. Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer risk in women with sclerosin adenosis. Cancer 1989; 64:1977-1983.spa
dc.relation.references115. Bassett LW, Gold RH, Mirra JA. Nonneoplastic breast calcifications in lipid cysts: development after excision and primary irradiation. AJR Am J Roentgenol 1982; 138:335.spa
dc.relation.references116. Ashton MA, Lefkowitz M, Tavassoli FA. Epithelioid stromal cells in lymphocytic mastitis: a source of confusión with invasive carcinoma. Mod Pathol 1994; 7:49-54.spa
dc.relation.references117. Feder JM, de paredes ES, Hogge JP, Wilken JJ. Unusual breast lesions: radiologic-pathologic correlation. Radiographics 1999; 19:s11-s26.spa
dc.relation.references118. Hermann G, Schwartz IS. Focal fibrous disease of the breast: mammographic detection of an unappreciated condition. AJR Am J Roentgenol 1983; 140:1245.spa
dc.relation.references119. Cohen MI, Matthies HJ, Mintzer RA, et al. Indurative mastopathy: a cause of false-positivemammograms. Radiology 1985; 155:69.spa
dc.relation.references120. Rickert RR, Kalisher L, Hutter RVP. Indurative mastopathy: a benign sclerosing lesion of breast with radial scar which may simulate carcinoma. CA Cancer J Clin 1981; 47:561.spa
dc.relation.references121. Wellings SR, Alpers CE. Subgross pathologic features and incidence of radial scars in the breast. Hum Pathol 1984; 15:475-479.spa
dc.relation.references122. Nielson M, Jensen J, Andersen JA. An autopsy study of radial scar in the female breast. Histopathology 1985; 9:287-295.spa
dc.relation.references123. Orel SG, Evers K, Yeh IT, Troupin RH. Radial scar with microcalcifications: radiologi-pathologic correlation. Radiology 1992; 183:470-482.spa
dc.relation.references124. Stalsberg H, Thomas DB. Age distribution of histologic types of breast cancer. Int J Cancer 1993; 54:1-7.spa
dc.relation.references125. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Seming Diagn Pathol 1994; 11:167-180.spa
dc.relation.references126. Ernster VL, Barclay J, Kerlikowske K, et al. incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913-918.spa
dc.relation.references127. Feig SA, Shaber GS, Patchefsky AS, et al. Tubular carcinoma of the breast. Radiology 1978; 129:311.spa
dc.relation.references128. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast: treatment by local escisión and surveillance alone. Cancer 1992; 70:2468-2474.spa
dc.relation.references129. Tabar L. The impact of breast cancer screening with mammography in women aged 40-49 years. Presented at the Falun Conference., March 21-22, 1996. Falun, Sweden.spa
dc.relation.references130. Stalsberg H, Thomas DB. Age distribution of histologic types of breast cancer. Int J Cancer 1993; 54:1-7.spa
dc.relation.references131. Meyer JM, Amin E, Lindfors KK, et al. Medullary carcinoma of the breast: mammographic and sonographic features. Radiology 1989; 170:79-82.spa
dc.relation.references132. Giles R, Lesnik A, Guinebretiere J, et al.apocrine carcinoma: clinical and mammographic features. Radiology 1994; 190:495-497.spa
dc.relation.references133. Foote FW, Stewart FW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol 1941; 17:491-496.spa
dc.relation.references134. Rosen PP, Kosloff C, Lieberman PH et al. lobular carcinoma in situ of the breast: long term follow-up. Cancer 1974; 34:554-563.spa
dc.relation.references135. Wheeler JE, Enterline HT, Roseman JM, et al. Lobular carcinoma in situ of the breast: long term follow up. Cancer 1974; 34:554-563.spa
dc.relation.references136. Webber BL, Heise H, Niefeld JP, Cosa J. risk of subsequent contralateral breast carcinoma in a population of patients with in situ breast carcinoma. Cancer 1981; 47:2928-2932.spa
dc.relation.references137. Pope TL, Fechner RE, Wilhelm MC, et al. Lobular carcinoma in situ of the breast: mammographic features. Radiology 1988; 168:63-66.spa
dc.relation.references138. Beute BJ, Kalisher L, Hutter RVP. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol 191; 157:257-265.spa
dc.relation.references139. Sickles EA. The subtle and atypical mammographic features of invasive lobular carcinoma. Radiology 1991; 178:25-26.spa
dc.relation.references140. Hart WR, Bauer RC, Oberman HA. Cystosarcoma phyllodes: a clinicopathologic study of twenty-six hypercellular periductal stromal tumors of the breast. Am J Clin Pathol 1978; 70:211.spa
dc.relation.references142. Toombs BD, Kalisher L. Metastatic disease to the breast: clinical, pathologic, and radiologic features. AJR Am J Roentgenol 1977; 129:673.spa
dc.relation.references143. Falkenberry S, Legare R. Risk factors for breast cancer. Obst and Gyn Clin of N Am; 2002:29: 159-172.spa
dc.relation.references144. George H Perkins and Lavinia P Middleton Breast cancer in men 2003;327;239-240 BMJ.spa
dc.relation.references145. Landis SH, Murria T, Bolden S et al. Cancer statistics 1998. CA Cancer J Clin 1998; 48:6-29.spa
dc.relation.references146. Ries LAG, Miller BA, Hankey BF et al (eds). SEER Cancer Statistics Review, 1973 1991:Tables and Graphs. NIH publication number 94 2789. Bethesda, MD, US Department of Health and Human Services, National Cancer Institute, 1994.spa
dc.relation.references147. Parkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents Vol.VIII. International Agency for research on Cancer [IARC], Lyon, France, IARC Scientific Publication No. 155. 2002.spa
dc.relation.references148. Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE, Bhatanagar D: BRCA1 and BRCA2 in Indian Breast.Cancer patients. Hum Mut 2002, 20:473-474.spa
dc.relation.references149. Becher H, Schmidt S and Chang-Claude J. Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assesing main effects and possible gene-environment interaction. Int J Epidemiol 2003; 32:38-48.spa
dc.relation.references150. Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994; 73:643–651.spa
dc.relation.references151. Miki Y, Swensen J, Shattuck-Eidens D. et al. Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66–71.spa
dc.relation.references152. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378(21/28):789–792.spa
dc.relation.references153. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131:961–72.spa
dc.relation.references154. Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651spa
dc.relation.references155. Saxena S, Rekhi B, Bansal A, Bagga A, Ch and S Murthy N. Clinico-morphological patterns of breast cancer ncluding family history in a New Delhi hospital, India-A cross-sectional study World Journal of Surgical Oncology 2005, 3:67spa
dc.relation.references156. Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarker Prev. 1999; 8:855-861.spa
dc.relation.references157. Healy E, Cook E, Orav E, Schnitt S, Connolly J, Harris J. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993; 11:1545-1552.spa
dc.relation.references158. Mandelson MT, Oestreicher N, Porter PL et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081–1087.spa
dc.relation.references159. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic Breast Density and Family History of Breast Cancer. Journal of the National Cancer Institute, Vol. 95, No. 7, April 2, 2003.spa
dc.relation.references160. Love SM, Gelman RS, Silen W. Fibrocystic ‘‘disease’’ of the breast—a nondisease? N Engl J Med 1982; 307:1010–1014.spa
dc.relation.references161. Page DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast associated with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996; 5:29–32.spa
dc.relation.references162. Page DL, Vander Zwaag R, Rogers LW et al. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978; 61:1055–1063. 169.spa
dc.relation.references163. Berg WA, Campassi CI, Ioffe OB. Cystic Lesions of the Breast: Sonographic-Pathologic Correlation. Radiology 2003; 227:183–191.spa
dc.relation.references164. Kelsey JL. Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993:15; 36-47.spa
dc.relation.references165. Mac-Mahon B. Reproduction and cancer of the breast. Cancer 1993; 71:3185-3188.spa
dc.relation.references166. Mac-Mahon B, Cole P Lin TM et al. Age at first birth and breast cancer risk. World Health.spa
dc.relation.references167. Lambe M, Hsich C-C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994; 331:5–9.spa
dc.relation.references168. Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001; 12:68–73.spa
dc.relation.references169. Chie WC, Hsieh C, Newcomb PA et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 2000; 151:715–722.spa
dc.relation.references170. Bernier MO, Plu-Bureau G, Bossard N. Breastfeeding and risk of breast cancer: A meta analisys of publuished studies. Hum Reprod Update 2000; 6: 374-386.spa
dc.relation.references171. Zheng T, Holford TR, Mayne ST et al. Lactation and breast cancer risk: A case control study in Connecticut. Br J Cancer 2001; 84:1472-1476.spa
dc.relation.references172. Torgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures. JAMA 2001285:2891–2897.spa
dc.relation.references173. Beral V, Bull D, Doll R et al. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350:1047–1059.spa
dc.relation.references174. Hofseth LJ, Raafat AM, Osuch JR et al. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999; 84:4559–4565.spa
dc.relation.references175. Ross RK, Paganini-Hill A, Wan PC et al. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000; 92:328–332.spa
dc.relation.references176. Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000; 283:485–491.spa
dc.relation.references177. Psaty BM, Smith NL, Lemaitre RN et al. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 2001285:906–913.spa
dc.relation.references178. Spinler SA, Hilleman DE, Cheng JW et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001; 35:589–617.spa
dc.relation.references179. Silvera SA, Miller AB, Rohan TE. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control. 2005 Nov;16(9):1059-63.spa
dc.relation.references180. Muti P, Trevisan M, Micheli A et al. Alcohol consumption and total estradiol in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:189–191.spa
dc.relation.references181. Dorgan JF, Baer DJ, Albert PS et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001; 93:710–715spa
dc.relation.references182. Lash TL, Aschengrau A. Alcohol drinking and risk of breast cancer. The Breast Journal 2000; 6:396–399.spa
dc.relation.references183. Smith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998; 279:535–540.spa
dc.relation.references184. Couch FJ, Cerhan JR, Vierkant RA, et al: Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10: 327–332, 2001.spa
dc.relation.references185. Lee IM, Rexrode KM, Cook NR et al. Physical activity and breast cancer risk: The Women’s Health Study (United States). Cancer Causes Control 2001; 12:137–145.spa
dc.relation.references186. Matthews CE, Shu XO, Jin F et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 2001; 84:994–1001.spa
dc.relation.references187. Mc Donald s, Saslow D and Alciati MH. Performance and reporting of clinical breast examination: A review of the literature. CA Canver J Clin 2004;54:354-361.spa
dc.relation.references188. Patiño JH, Hincapie AL, Restrepo AL. Biopsia percutánea de lesiones mamograficas no palpables: Estereotaxia y ecografía. Revista Colombiana de radiología 2002; 13: 1141-1148spa
dc.relation.references189. Leung J, Sickles E. The probably benign assessment. Radiol Clin N Am 2007; 45: 773-789.spa
dc.contributor.cvlacRey Serrano, Juan José [0000265306]*
dc.contributor.googlescholarRey Serrano, Juan José [es&oi=ao]*
dc.contributor.orcidRey Serrano, Juan José [0000-0002-6946-2444]spa
dc.contributor.scopusRey Serrano, Juan José [54793298100]spa
dc.subject.lembCiencias médicasspa
dc.subject.lembRadiologíaspa
dc.subject.lembDiagnóstico por imágenesspa
dc.subject.lembCáncer de mamaspa
dc.subject.lembPatología mamariaspa
dc.subject.lembNeoplasias de mamaspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.description.abstractenglishBreast cancer is the most common invasive tumor in women, with more than a million cases and nearly 600,000 deaths a year worldwide (1), with higher incidence rates in industrialized countries, such as the United States, Australia and Western European countries, which may be related to changes in reproductive patterns as well as increased use of mammography (2, 3, 4 and 5). The incidence rate is not the same for all racial and ethnic groups, reflecting varying degrees of socioeconomic development and cultural characteristics (6). Average annual incidence rates adjusted for age from 1996 to 2000 were 140.8 cases / 100,000 among white women, 121.7 among African-Americans, 97.2 among Asian-American / Pacific Islander, 89.8 among Hispanic and 58 in American Indians / Alaska Natives (6). In Latin America, according to the International Union for Cancer Control, Uruguay, Argentina and Chile have the highest incidence and mortality rates from breast cancer, while in Peru and Mexico cervical cancer continues to rank first. Worldwide, there is a trend towards an increase in breast cancer while cervical cancer decreases, however in Colombia the incidence of cancer with an age-adjusted rate was 36.8 per hundred thousand for the cervix and 30 per hundred thousand for mom.eng
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalBiopsias percutáneasspa
dc.subject.proposalLesiones mamariasspa
dc.subject.proposalEcografíaspa
dc.subject.proposalMamografíaspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.contributor.researchgroupObservatorio de Salud Pública de Santanderspa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Ficheros en el ítem

Thumbnail
Nombre:
2008_Tesis_Sandra_Patricia_Roj ...
Tamaño:
964.9Kb
Formato:
PDF
Descripción:
Tesis
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia